InvestorsHub Logo
Followers 0
Posts 185
Boards Moderated 0
Alias Born 07/02/2007

Re: bloomvest post# 7498

Wednesday, 10/17/2007 12:00:00 AM

Wednesday, October 17, 2007 12:00:00 AM

Post# of 146291
It sounds more like the other way around. The investors pulled out of investing. They would have to pay for the shares up front at the rate of 50 cents per share, but couldn't sell them until they got registered a few months later.

By that time, they would probably be worth about 40 cents a share. Who would want to do that?

Will you be hiring any professional pharma executives?

Why bother? Does it really look like they will ever put a product out?

18 months ago, Seymour said "INDA's in 18 months."

Now, if you read the annual report, they say, "INDA's in the 2008-2009 fiscal year". If it happens halfway through the year that means... INDA's in 18 months.

18 months from now... look forward to hearing the same thing.

Face it, they don't have a clue as to when anything will be done. Or where the money to fund all these projects would come from. They constantly issue guesses and goals and projections that never pan out.

If the Dengue studies perform well, whats the next step?

What Dengue studies? The filing lists the current dengue drug status as "early R & D", same as the HIV drugs. Not even in preclinical testing.

Will there be a program to create investor awareness about NNVC?

People are already aware of NNVC. They just don't like it.

Is it possible to collaborate with Big Pharma before Human studies?

What exactly about this operation would impress Big Pharma? The lack of funding, or the lack of results?







Hype is a dangerous tool in the wrong hands.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News